Trametinib DMSO solvate
| CAS No. | 1187431-43-1 | Cat. No. | BCP06093 |
| Name | Trametinib DMSO solvate | ||
| Synonyms | GSK-1120212 DMSO solvate;GSK1120212;GSK-1120212;GSK1120212;Trametinib;JTP-74057;JTP 74057;JTP74057; | ||
| Formula | C28H29FIN5O5S | M. Wt | 693.53 |
| Description | Trametinib DMSO solvate is a solvated form of trametinib at 1:1 molar ratio of trametinib to dimethyl sulfoxide. Trametinib, also known as GSK1120212, GSK212 or JTP74057, is an approved and new targeted drug for the treatment of melanoma. It is a powerful and selective MEK1/MEK2 inhibitor which can effectively prevent cancer cell proliferating and can induce cell apoptosis, and increase the life of patients. | ||
| Pathways | MAPK Pathway | ||
| Targets | MEK/ERK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.